Anti-Human CD30 Recombinant Antibody(Brentuximab)

Name: Anti-Human CD30 Recombinant Antibody(Brentuximab)
Brand: KMD Bioscience
SKU: YR1614

YR1614

科研级 Brentuximab ( 本妥昔单抗 ), Anti-CD30 Recombinant Antibody, Research Grade Brentuximab

DATASHEET MSDS

Product Description

Alias	科研级 Brentuximab ( 本妥昔单抗 ), Anti-CD30 Recombinant Antibody, Research Grade Brentuximab
Catalog Number	YR1614
Molecular Name	Brentuximab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	Human IgG1
Formulation	PBS, pH7.5
Background	Brentuximab vedotin (INN, trade name Adcetris) is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL), a type of T cell non-Hodgkin lymphoma. It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL.
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Molecular Weight	150 kDa
Target	CD30[Homo sapiens]

Login